Lateralization of the Inferior Alveolar Nerve After Repositioning of the Bone Window Versus Stick… (NCT04590339) | Clinical Trial Compass
CompletedNot Applicable
Lateralization of the Inferior Alveolar Nerve After Repositioning of the Bone Window Versus Sticky Bone Augmentation
Egypt20 participantsStarted 2018-10-25
Plain-language summary
Rehabilitation of edentulous posterior mandibular regions with severe ridge atrophy using implants is subject to anatomical, surgical, and biological difficulties. In many cases, the bone is severely atrophied that sufficiently long fixtures cannot be placed without encroaching on the inferior alveolar nerve (IAN). IANL is defined as the lateralization of inferior alveolar neurovascular bundle posterior to the mental foramen, with preservation of the incisive nerve; exposure and traction are used to deflect the IAN laterally while the implants are placed.
Who can participate
Age range
25 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients suffering from unilateral posterior mandibular edentulism and having \< 8 mm of bone above the mandibular canal.
* The width of the ridge should be \> 4mm.
* The patient should be psychologically accepting the implant and the involved procedures.
* The patients should have adequate oral hygiene and adequate bone quality.
Exclusion Criteria:
* Any absolute contraindication for implant surgery such as uncontrolled diabetes mellitus, blood and/or bleeding disorders, serious osseous defects…etc.
* Any relevant systemic disease directly affecting bone metabolism and healing.
* Any habits that might reduce the blood flow and retard healing such as heavy smoking and alcoholism.
* A history of any grafting procedure at the designated area.
* Patient with thick cortical bone buccally and a thin neurovascular bundle.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in neurosensory recovery and sensation regaining over 6 months compared to normal (taken at base line)
Timeframe: 1 month, 3 months and 6 months
2
Clinical assessment of the change in neurosensory function recovery using Static light touch detection test.
Timeframe: 1 week, 1 month, 3 months and 6 months
3
Clinical assessment of the change in neurosensory function recovery using Brush stroke discrimination test.
Timeframe: 1 week, 1 month, 3 months and 6 months
4
Clinical assessment of the change in neurosensory function recovery using two point discrimination test
Timeframe: 1 week, 1 month, 3 months and 6 months
5
Clinical assessment of the change in neurosensory function recovery using pin-prick sensation test.